(Q45752772)

15 December 2017

title

Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay (English)

1 reference

15 December 2017

1 reference

Gürtler L

1

1 reference

15 December 2017

Mühlbacher A

2

1 reference

15 December 2017

Michl U

3

1 reference

15 December 2017

Hofmann H

4

1 reference

15 December 2017

Paggi GG

5

1 reference

15 December 2017

Bossi V

6

1 reference

15 December 2017

Thorstensson R

7

1 reference

15 December 2017

G-Villaescusa R

8

1 reference

15 December 2017

Eiras A

9

1 reference

15 December 2017

Hernandez JM

10

1 reference

15 December 2017

Melchior W

11

1 reference

15 December 2017

Donie F

12

1 reference

15 December 2017

Weber B

13

1 reference

15 December 2017

publication date

1 November 1998

1 reference

15 December 2017

Journal of Virological Methods

published in

1 reference

15 December 2017

volume

75

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

27-38

1 reference

15 December 2017

Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Sensitivity of HIV-antibody assays determined by seroconversion panels.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Infectious disease markers in blood donors in northern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

Early detection of antibodies to HIV-1 by third-generation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900094-9

7 January 2021

10.1016/S0166-0934(98)00094-9

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017